WeVote
Log In

Bill

Bill

SF 1574

Commissioner of human services selection of a state pharmacy benefit manager through procurement requirement provision, commissioner of human services entrance into a master contract with the state pharmacy benefit manager requirement provision, and program authority and eligibility requirements specification provision

2025-2026 Regular Session Introduced by Jim Abeler and 4 co-sponsors

DHS must run a competitive procurement to select a state-level PBM, enter a master contract to administer DHS drug benefits, and define authority and eligibility for those programs

Author added Boldon
#commerceandcommercedepartment #drugsandmedicine #humanservicesandhumanservicesdepartment #insurance-health
0
WeVote Research Nonpartisan
Bill Summary · SF 1574

Summary of Senate File 1574 (SF 1574)

Overview

SF 1574 would require the Minnesota Department of Human Services (DHS) to use a procurement process to select a state-level pharmacy benefit manager (PBM), enter into a master contract with that PBM, and specify program authority and eligibility requirements related to the DHS drug-benefit programs. The bill appears to centralize oversight of drug benefits through a single PBM arrangement and to clarify how DHS administers and determines eligibility for related programs.

  • Introduced: February 20, 2025
  • Referred to: Health and Human Services
  • Author (as of latest action): Boldon
  • Companion: HF 2242

Key Provisions (high-level, based on the bill’s title)

  • Procurement Requirement for a State PBM:

    • DHS would be compelled to conduct a competitive procurement process to select a state-level PBM to administer prescription drug benefits.

  • Master Contract with the State PBM:

    • DHS would enter into a master contract with the selected PBM. The master contract would set terms for the administration of drug benefits across DHS programs.

  • Program Authority and Eligibility Specifications:

    • The bill would specify DHS’s authority to implement the PBM program and would define eligibility requirements for participants in programs affected by the PBM arrangement.

Note: The specific details, including contract terms, formulary provisions, rebates, cost-sharing, timelines, and any exemptions or transition provisions, are not included in the summary provided here. The exact language would be in the bill text.

Affected Parties and Impacts

  • Primary: Minnesota Department of Human Services (DHS)
  • Public sector entity involved: State-level Pharmacy Benefit Manager (PBM, once selected)
  • Program beneficiaries: Individuals enrolled in DHS-administered drug-benefit programs (e.g., portions of Medicaid/Managed Care or other DHS drug benefits)
  • Providers and pharmacies: May be impacted by contract terms, reimbursement structures, and formulary decisions under the PBM arrangement

Procedural and Timeline Aspects

  • Introduction date and actions:
    • February 20, 2025: Introduced and referred to Health and Human Services
    • March 10, 2025: Author Boldon added
  • Status: bill with an author addition (Boldon)
  • Relationship to other legislation:
    • Companion bill: HF 2242 (House companion)

What to Watch For

  • The full bill text will provide specifics on:
    • Procurement process details (bidding timeline, evaluation criteria)
    • Master contract requirements (scope of services, performance standards, cost controls, rebates)
    • How program authority and eligibility are defined and any changes to existing DHS programs
    • Implementation timelines, transition provisions, and any sunset or renewal terms
  • Fiscal impact and potential cost savings or reallocations associated with centralizing drug-benefit administration

Additional Notes

  • This summary reflects information available from the bill’s introductory materials and annotated actions. For a complete understanding, consult the official bill text and committee analyses on the Minnesota Legislature website.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.